New Medical Centre Alexandria results, Q3 2025
Net profit, assets, equity and cash flow for Q3 2025, against the same period a year earlier, from the published financial statements.
Net profit20.19 millionEGP · +40.6% vs the same period a year earlier
Shareholders' equity263 millionEGP · +23.9% vs the same period a year earlier
Operating cash flow7.73 millionEGP · −43.2% vs the same period a year earlier
In short
- New Medical Centre Alexandria's net profit for Q3 2025 was about 20.19 million EGP, up +40.6% from 14.35 million EGP in Q3 2024.
- Operating cash flow for Q3 2025 was positive at 7.73 million EGP.
Key lines against the same period a year earlier
This periodQ3 2024Change
Net profit20.19 million14.35 million+40.6%
Gross profit48.64 million40.43 million+20.3%
Total assets—327 million—
Total liabilities—114 million—
Shareholders' equity263 million213 million+23.9%
Total liabilities and equity431 million327 million+31.9%
Operating cash flow7.73 million13.6 million−43.2%
Investing cash flow-2.58 million-12.3 million+79.0%
Financing cash flow———
Net change in cash—1.31 million—
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
New Medical Centre Alexandria's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy